{"raw_mentions": "The compounds of the present invention are GABAA receptor subtype ligands having a binding affinity (Ki) for the \u03b12 and/or \u03b13 subunit, as measured in the assay described hereinbelow, of less than 1 nM."}
{"final_json": [{"molecule_name": null, "protein_target_name": "GABAA receptor subtype", "binding_metric": "Ki", "value": "<1", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The compound of the accompanying Examples was tested in the above assay, and was found to possess a Ki value for displacement of [<sup>3</sup>H]- flumazenil from the \u03b12 and or \u03b13 subunit of the human GABAA receptor of less than 1 nM.\n* 50 \u03bcl of [<sup>3</sup>H]-fLumazenil (final concentration for \u03b1l\u03b23\u03b32: 1.8 nM; for \u03b12\u03b23\u03b32: 1.8 nM; for \u03b13\u03b23\u03b32: 1.0 nM).\n* test compound or flunitrazepam (to determine non-specific binding), 10 \u03bcM final concentration."}
{"final_json": [{"molecule_name": "compound of the accompanying Examples", "protein_target_name": "\u03b12 and or \u03b13 subunit of the human GABAA receptor", "binding_metric": "Ki", "value": "<1", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "[<sup>3</sup>H]-fLumazenil", "protein_target_name": "\u03b1l\u03b23\u03b32", "binding_metric": null, "value": "1.8", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "[<sup>3</sup>H]-fLumazenil", "protein_target_name": "\u03b12\u03b23\u03b32", "binding_metric": null, "value": "1.8", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "[<sup>3</sup>H]-fLumazenil", "protein_target_name": "\u03b13\u03b23\u03b32", "binding_metric": null, "value": "1.0", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "test compound or flunitrazepam", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "\u03bcM", "is_logarithmic": false}]}
